References
Coleman CN, Turrisi AT. Radiation and chemotherapy sensitizers and protectors. Crit Rev Oncol Hematol 1990; 10: 225–52
Bentzen SM, Overgaard M, Thams HD, et al. Early and late normal-tissue injury after post-mastectomy radiotherapy alone or combined with chemotherapy. Int J Radiat Biol 1989; 56: 711–5
Azria D, Gourgou S, Sozzi WJW, et al. Concomitant use of tamoxifen with radiotherapy enhances subcutaneous breast fibrosis in hypersensitive patients. Br J Cancer 2004; 91: 1251–60
Schweitzer VG, Juillard GJ, Bajada CL, et al. Radiation recall dermatitis and pneumonitis in a patient treated with paclitaxel. Cancer 1995; 76: 1069–72
Camidge R, Price A. Characterizing the phenomenon of radiation recall dermatitis. Radiother Oncol 2001; 59: 237–45
Friedlander PA, Bansal R, Schwartz L, et al. Gemcitabine-related radiation recall preferentially involves internal tissue and organs. Cancer 2004; 100: 1793–9
Parry BR. Radiation recall induced by tamoxifen [letter]. Lancet 1992; 340: 49
Bostrom A, Sjolin-Forsberg G, Wilking G, et al. Radiation recall: another call with tamoxifen. Acta Oncol 1999; 38: 955–9
Kodym E, Kalinska R, Ehringfeld C, et al. Frequency of radiation recall dermatitis in adult cancer patients. Onkologie 2005; 28: 18–21
Bokemeyer C, Lampe C, Heneka M, et al. Paclitaxel-induced radiation recall dermatitis. Ann Oncol 1996; 7: 755–6
Magne N, Benezery K, Otto J, et al. Radiation recall dermatitis after docetaxel and external beam radiotherapy: report of two cases and review of the literature. Cancer Radiother 2002; 6: 281–4
Jimeno A, Ciruelos EM, Castellano D, et al. Radiation recall dermatitis induced by pegylated liposome doxorubicin. Anticancer Drugs 2003; 14: 575–6
Schwartz BM, Khuntia D, Kennedy AW, et al. Gemcitabine-induced radiation recall dermatitis following whole pelvic radiation therapy. Gynecol Oncol 2003; 91: 421–2
Borroni G, Vassallo C, Brazzelli V, et al. Radiation recall dermatitis, panniculitis, and myositis following cyclosphosphamide therapy: histopathologic findings of a patient affected by multiple myeloma. Am J Dermatopathol 2004; 26: 213–6
Hureaux J, Le Guen Y, Tuchais C, et al. Radiation recall dermatitis with pemetrexed. Lung Cancer 2005; 50: 255–8
Piérard GE, Paquet P, Piérard-Franchimont C, et al. Adverse cutaneous reactions to chemotherapy, and their treatments. Rev Med Lie`ge 2007; 62: 457–62
Bernier J, Bonner J, Vermoken JB, et al. Consensus guidelines for the management of radiation dermatitis and coexisting acne-like rash in patients receiving radiotherapy plus EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck. Ann Oncol 2008; 19: 142–9
Ristic B. Radiation recall dermatitis. Int J Dermatol 2004; 43: 627–31
Singer EA, Warren RD, Pennanen MF, et al. Tamoxifen-induced radiation recall dermatitis. Breast J 2004; 10: 170–1
Ayoola A, Lee YJ. Radiation recall dermatitis with cefotelan: a case study. Oncologist 2006; 11: 1118–20
Bonner JA, Ang K. More on severe cutaneous reaction with radiotherapy and cetuximab. N Engl J Med 2007; 357: 1872–3
Williams B, Roth D, Callen J. Ultraviolet recall associated with etoposide and cyclophosphamide therapy. Clin Exp Dermatol 1993; 18: 452–3
Chu CY, Yang CH. Docetaxel-induced recall dermatitis on previous laser treatment sites. Br J Dermatol 2005; 153: 441–3
Raghavan V, Bloomer W, Merkel D. Taxol and radiation recall dermatitis [letter]. Lancet 1993; 341: 1354
Shenkier T, Gelmon K. Paclitaxel and radiation-recall dermatitis [letter]. J Clin Oncol 1994; 12: 439
Phillips K, Urch M, Bishop J. Radiation recall dermatitis in a patient treated with paclitaxel [letter]. J Oncol 1995; 13: 305
McCarty M, Peake M, Lillis P, et al. Paclitaxel-induced radiation recall dermatitis. Med Pediatr Oncol 1996; 27: 185–6
Yeo W, Leung S, Johnson P. Radiation-recall dermatitis with docetaxel: establishment of a requisite radiation threshold. Eur J Cancer 1996; 33: 698–9
Camidge DR, Kunkler IH. Docetaxel-induced radiation recall dermatitis and successful rechallenge without recurrence. Clin Oncol 2000; 12: 272–3
Piorth MD, Krempien R, Wannemmacher M, et al. Radiation recall dermatitis from docetaxel. Onkologie 2002; 25: 438–40
Barlesi F, Tummino C, Tasei AM, et al. Unsuccessful rechallenge with pemetrexed after a previous radiation recall dermatitis. Lung Cancer 2006; 54: 423–5
Smith KJ, Germain M, Skelton H. Histopathologic features seen with radiation recall or enhancement eruptions. J Cutan Med Surg 2002; 6: 535–40
Wright EG. Radiation-induced genomic instability in haemopoietic cells. Int J Radiat Biol 1998; 74: 681–7
Seymour CB, Mothersill C, Alper T. High yields of lethal mutations in somatic mammalian cells that survive ionizing radiation. Int J Radiat Biol Relat Stud Phys Chem Med 1986; 50: 167–79
Hellman S, Botnick LE. Stem cell depletion: an explanation of the late effects of cytotoxins. Int J Radiat Oncol Biol Phys 1977; 2: 181–4
Camidge R, Price A. Radiation recall dermatitis may represent the Koebner phenomenon [letter]. J Clin Oncol 2002; 20: 4130
Vergara G, Vargas-Machuca I, Pastor MA, et al. Localization of Sweet’s syndrome in radiation-induced locus minoris resistentiae. J Am Acad Dermatol 2003; 49: 907–9
Kim JH, Krivda SJ. Lichen planus confined to a radiation therapy site. J Am Acad Dermatol 2002; 46: 604–5
Low GJ, Keeling JH. Ionizing radiation-induced pemphigus: case presentations and literature review. Arch Dermatol 1990; 126: 1319–23
Veness MJ, Dwyer PK. Erythema multiforme-like reaction associated with radiotherapy. Australas Radiol 1996; 40: 334–7
Duncan KO, Tigelaar RE, Bolognia JL. Stevens-Johnson syndrome limited to multiple sites of radiation therapy in a patient receiving phenobarbital. J Am Acad Dermatol 1999; 40: 493–6
Khafaga YM, Jamshed A, Allam AA, et al. Stevens-Johnson syndrome in a patient on phenytoin and cranial radiotherapy. Acta Oncol 1999; 38: 111–6
Micali G, Linthicum K, Han N, et al. Increased risk of erythema multiforme major with combination anticonvulsant and radiation therapies. Pharmacotherapy 1999; 19: 223–7
Eralp Y, Aydiner A, Tas F, et al. Stevens-Johnson syndrome in a patient receiving anticonvulsant therapy during cranial irradiation. Am J Clin Oncol 2001; 24: 347–50
Aguiar D, Pazo R, Duran I, et al. Toxic epidermal necrolysis in patients receiving anticonvulsants and cranial irradiation: a risk to consider. J Neurooncol 2004; 66: 345–50
Ahmed I, Reichenberg J, Lucas A, et al. Erythema multiforme associated with phenytoin and cranial radiation therapy: a report of three patients and review of the literature. Int J Dermatol 2004; 43: 67–73
Acknowledgments
No sources of funding were used to assist in the preparation of this article. The authors have no conflicts of interest that are directly relevant to the content of this article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Quatresooz, P., Piérard, G.E. A Docetaxel-Induced Rash on a Radiotherapy Port. Am J Clin Dermatol 11, 367–369 (2010). https://doi.org/10.2165/11537010-000000000-00000
Published:
Issue Date:
DOI: https://doi.org/10.2165/11537010-000000000-00000